Detalles de la búsqueda
1.
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.
Breast Cancer Res Treat
; 155(3): 521-30, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26875185
2.
Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies.
Cancer Chemother Pharmacol
; 74(2): 359-65, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24934865
Resultados
1 -
2
de 2
1
Próxima >
>>